Brief: Celltrion Says Awarded Up To $626 Mln From Department Of Defense To Supply Covid-19 Point-Of-Care Rapid Antigen Test Kits
23/09/2021 08:20
Sept 23 (Reuters) - Celltrion Inc 068270.KS :
* CELLTRION AWARDED UP TO $626 MILLION FROM THE DEPARTMENT
OF
DEFENSE TO SUPPLY COVID-19 POINT-OF-CARE (POC) RAPID ANTIGEN
TEST KITS
Source text for Eikon: ID:nBw33Fpw1a
Further company coverage: 068270.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celltrion
See all newsBrief: Celltrion Inc To Acquire 100 Billion Won Worth Of Own Shares
Brief: Celltrion Q1 Operating. Profit 322 Billion Won, Up 115% Y/Y
Brief: Celltrion To Cancel 100 Billion Won Treasury Shares
Brief: Celltrion Plans Phase 3 Clinical Trials For Keytruda Biosimilar With 220 Patients
Brief: Celltrion To Buy 100 Billion Won Of Own Shares